EODData

FRA, 8N1: BIOSERGEN AB

28 Nov 2025
LAST:

0.0398

CHANGE:
 0.00
OPEN:
0.0384
HIGH:
0.0398
ASK:
0.0000
VOLUME:
10.0K
CHG(%):
0.51
PREV:
0.0396
LOW:
0.0350
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
28 Nov 250.03840.03980.03500.039810.0K
27 Nov 250.03760.03960.03760.039610.0K
26 Nov 250.03820.03840.03760.038410.0K
25 Nov 250.03900.04120.03880.039810.0K
24 Nov 250.04000.04140.03880.041410.0K
21 Nov 250.03840.04040.03760.038810.0K
20 Nov 250.04100.04100.03760.039610.0K
19 Nov 250.03900.04060.03900.040610.0K
18 Nov 250.04100.04100.03740.038610.0K
17 Nov 250.03660.04160.03660.041610.0K

PROFILE

Name:BIOSERGEN AB
About:Biosergen AB (publ), a biotech company, develops antifungal products. Its lead product is BSG005, an antifungal drug candidate for the treatment of invasive fungal infections in immunocompromised patients, including AIDS, cancer, and transplant recipients. The company was founded in 2004 and is based in Solna, Sweden.
Sector:Healthcare
Industry:Biotechnology
Address:Fogdevreten 2, Solna, Sweden, 171 65
Website:https://www.biosergen.net
ISIN:SE0016013460

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.49 
PEG Ratio:-0.02 
Price to Sales:12.11 
Price to Book:0.27 
Operating Margin:-6.61 
Return on Assets:-0.50 
Return on Equity:-0.95 
Revenue:71.2K 
Shares:234.82M 
Market Cap:9.35M 

TECHNICAL INDICATORS

MA5:0.040.0%
MA10:0.040.0%
MA20:0.041.8%
MA50:0.042.5%
MA100:0.043.3%
MA200:0.041.8%
STO9:46.67
STO14:59.09
RSI14:55.08
WPR14:-40.91
MTM14:0.00
ROC14:0.01 
ATR:0.00 
Week High:0.044.0%
Week Low:0.0413.7%
Month High:0.046.0%
Month Low:0.041.8%
Year High:0.0653.3%
Year Low:0.0265.8%
Volatility:62.24 

RECENT SPLITS

Date Ratio
01 Dec 20251-100